Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

LD 227 will safeguard providers and patients from out-of-state laws that ban or restrict care that is legal in Maine

(Portland, MAINE) – As attacks on reproductive health care and essential health care for transgender people continue in states across the country, Maine lawmakers will consider legislation to protect Maine providers and patients, from hostile actions by out-of-state actors.

The Maine legislature's Health Coverage, Insurance and Financial Services (HCIFS) Committee will hold a public hearing on LD 227, An Act Regarding Health Care in the State, sponsored by Rep. Anne Perry (D-Calais), at 1 p.m. today. 

This bill aims to ensure Maine's health care providers aren’t penalized under the laws of other states that have banned access to established, standard-of-care transgender health care and reproductive care and to ensure patients can continue to receive quality, legal, essential medical care in Maine. 

To date, 21 states across the country have enacted bans or near total bans on abortion. State and federal lawmakers opposed to comprehensive reproductive health care have acted to ban or restrict forms of contraception, and a court in Alabama issued a ruling recently imperiling in vitro fertilization in that state, causing providers to shut down IVF services. 

At least 23 states have banned access to safe and effective medical care for transgender adolescents and some have moved to restrict access to care for transgender adults.  

LD 227 is consistent with Governor Janet Mills’ July 2022 executive order safeguarding providers and patients of reproductive care in the wake of the Dobbs Supreme Court ruling overturning Roe v. Wade. It also builds on legislation passed by Maine lawmakers in June 2023 that protects reproductive health care providers from adverse actions by malpractice insurers. 

Statement from Lisa Margulies, Esq., Vice President of Public Affairs, Planned Parenthood Maine Action Fund and Planned Parenthood of Northern New England

“Full spectrum reproductive health care and gender-affirming health care are essential, lifesaving services that are safe and legal in Maine. With LD 227, our elected leaders have an opportunity to stand up for safe, legal medical care by protecting providers who offer that care and the patients who seek it. 

Since Dobbs, we have seen escalating attacks on abortion care and essential medical care for transgender people by extremists who are desperate to interfere with our personal medical decisions, with many state legislatures banning this basic, essential care. Maine is not immune to the disingenuous and harmful rhetoric spread by extremists opposed to people accessing safe, legal medical care, and it is critical that our lawmakers listen to the facts and act to protect providers, patients, and people who help patients access this care.” 

Statement from Polly Crozier, Director of Family Advocacy, GLBTQ Legal Advocates & Defenders (GLAD) 

“LD 227 is a straightforward bill to ensure that Maine law can continue to govern Maine health care. Maine is committed to protecting access to essential health care for transgender people and to reproductive health care, including abortion. Yet politicians in some states have shown their intent to prevent people from accessing this vital health care anywhere. This legislation will safeguard Maine’s health care infrastructure from hostile laws passed for political, not medical, purposes in other states and ensure Maine providers can continue to deliver high quality, standard-of-care medical care.” 

### 

Planned Parenthood Maine Action Fund is an independent, nonpartisan, not-for-profit membership organization formed as the advocacy and political arm of Planned Parenthood of Northern New England in Maine. PPNNE has four health centers in Maine and sees more than 12,000 patients a year. 

*** 

Through strategic litigation, public policy advocacy, and education, GLBTQ Legal Advocates & Defenders works in New England and nationally to create a just society free of discrimination based on gender identity and expression, HIV status, and sexual orientation. www.glad.org 

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of our Necessary Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.